{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:33:17Z","timestamp":1769628797341,"version":"3.49.0"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/01.fpc.0000236339.79916.07","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T16:43:31Z","timestamp":1209919411000},"page":"571-579","source":"Crossref","is-referenced-by-count":33,"title":["UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin"],"prefix":"10.1097","volume":"17","author":[{"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwendolyn E.","family":"Kuehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Bigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine F.","family":"Rimorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny D.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna W.","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210212","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/01.CIR.102.17.2022","article-title":"Aspirin and salicylate: an old remedy with a new twist","volume":"102","author":"Wu","year":"2000","journal-title":"Circulation"},{"key":"R2-1-20210212","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003088-198308040-00003","article-title":"Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs","volume":"8","author":"Verbeeck","year":"1983","journal-title":"Clin Pharmacokinet"},{"key":"R3-1-20210212","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11926-004-0009-0","article-title":"Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis","volume":"6","author":"Kurth","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"R4-1-20210212","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archinte.1981.00340030043009","article-title":"Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction","volume":"141","author":"Hirsh","year":"1981","journal-title":"Arch Intern Med"},{"key":"R5-1-20210212","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin Low-Dose Trial (SALT) of 75\u2009mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"R6-1-20210212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R7-1-20210212","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"R8-1-20210212","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bmj.307.6899.285","article-title":"Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme","volume":"307","author":"Logan","year":"1993","journal-title":"BMJ"},{"key":"R9-1-20210212","first-page":"123","article-title":"Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer","author":"Sandler","year":"1996","journal-title":"Important Adv Oncol"},{"key":"R10-1-20210212","first-page":"1322","article-title":"Aspirin use and risk of fatal cancer","volume":"53","author":"Thun","year":"1993","journal-title":"Cancer Res"},{"key":"R11-1-20210212","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-121-4-199408150-00001","article-title":"Aspirin use and the risk for colorectal cancer and adenoma in male health professionals","volume":"121","author":"Giovannucci","year":"1994","journal-title":"Ann Intern Med"},{"key":"R12-1-20210212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00365529609094766","article-title":"Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: a review of the epidemiological evidence","volume":"220","author":"Weiss","year":"1996","journal-title":"Scand J Gastroenterol Suppl"},{"key":"R13-1-20210212","doi-asserted-by":"crossref","first-page":"38261","DOI":"10.1074\/jbc.M005545200","article-title":"Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-Myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen","volume":"275","author":"Law","year":"2000","journal-title":"J Biol Chem"},{"key":"R14-1-20210212","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0049-3848(83)90365-1","article-title":"Aspirin: plasma concentration and effects","volume":"4","author":"Thiessen","year":"1983","journal-title":"Thromb Res Suppl"},{"key":"R15-1-20210212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0163-7258(91)90065-T","article-title":"Drug glucuronidation in humans","volume":"51","author":"Miners","year":"1991","journal-title":"Pharmacol Ther"},{"key":"R16-1-20210212","doi-asserted-by":"crossref","first-page":"28320","DOI":"10.1074\/jbc.M401396200","article-title":"Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation","volume":"279","author":"Basu","year":"2004","journal-title":"J Biol Chem"},{"key":"R17-1-20210212","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1124\/dmd.104.002527","article-title":"Glucuronidation of the aspirin metabolite salicylic acid by expressed UGTs and human liver microsomes","volume":"33","author":"Kuehl","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"R18-1-20210212","first-page":"127","article-title":"Interactions of m-xylene and aspirin metabolism in man","volume":"45","author":"Campbell","year":"1988","journal-title":"Br J Ind Med"},{"key":"R19-1-20210212","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0090-9556(24)14906-9","article-title":"Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans","volume":"27","author":"Dupont","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"R20-1-20210212","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/00498258609043527","article-title":"The metabolism of aspirin in man: a population study","volume":"16","author":"Hutt","year":"1986","journal-title":"Xenobiotica"},{"key":"R21-1-20210212","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cpt1972132258","article-title":"Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man","volume":"13","author":"Levy","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"R22-1-20210212","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2125.1980.tb04816.x","article-title":"Inter-individual differences in the glycine conjugation of salicylic acid [Proceedings]","volume":"9","author":"Caldwell","year":"1980","journal-title":"Br J Clin Pharmacol"},{"key":"R23-1-20210212","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1389200053586064","article-title":"Polymorphism of UDP-glucuronosyltransferase and drug metabolism","volume":"6","author":"Maruo","year":"2005","journal-title":"Curr Drug Metab"},{"key":"R24-1-20210212","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1124\/jpet.104.081968","article-title":"UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S)","volume":"313","author":"Krishnaswamy","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R25-1-20210212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00008571-199712000-00007","article-title":"Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications","volume":"7","author":"Ciotti","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R26-1-20210212","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.fpc.0000114771.78957.cb","article-title":"Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells","volume":"14","author":"Nagar","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R27-1-20210212","first-page":"3566","article-title":"CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk","volume":"61","author":"Bigler","year":"2001","journal-title":"Cancer Res"},{"key":"R28-1-20210212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jnci\/dji066","article-title":"Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma","volume":"97","author":"Chan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R29-1-20210212","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.fpc.0000174786.85238.63","article-title":"No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPAR\u03b4 and PPAR\u03b3 act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma","volume":"15","author":"McGreavey","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"R30-1-20210212","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2125.2005.02495.x","article-title":"Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid","volume":"60","author":"van Oijen","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"R31-1-20210212","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00008571-199906000-00009","article-title":"UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations","volume":"9","author":"Lampe","year":"1999","journal-title":"Pharmacogenetics"},{"key":"R32-1-20210212","first-page":"SN7(85)","article-title":"Genetic polymorphisms of UGT1A6 in a Japanese population","volume":"20","author":"Saeki","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"R33-1-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00008571-199704000-00010","article-title":"UGT1*1 genotyping in a Canadian Inuit population","volume":"7","author":"Monaghan","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R34-1-20210212","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","article-title":"Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","volume":"95","author":"Beutler","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"R35-1-20210212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-4347(95)00337-1","article-title":"Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography","volume":"675","author":"Liu","year":"1996","journal-title":"J Chromatogr B"},{"key":"R36-1-20210212","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3109\/00498259009046898","article-title":"Comparative metabolism of high doses of aspirin in man and rat","volume":"20","author":"Patel","year":"1990","journal-title":"Xenobiotica"},{"key":"R37-1-20210212","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2165\/00003088-198510020-00004","article-title":"Clinical pharmacokinetics of the salicylates","volume":"10","author":"Needs","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"R38-1-20210212","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1248\/bpb.27.706","article-title":"Pharmacokinetics and metabolic rates of acetyl salicylic acid and its metabolites in an Otomi ethnic group of Mexico","volume":"27","author":"Lares-Asseff","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"R39-1-20210212","first-page":"83","article-title":"Saliva\u2013plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications","volume":"57","author":"Posti","year":"1982","journal-title":"Pharm Acta Helv"},{"key":"R40-1-20210212","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.2042-7158.1987.tb06967.x","article-title":"Salivary secretion of paracetamol in man","volume":"39","author":"Kamali","year":"1987","journal-title":"J Pharm Pharmacol"},{"key":"R41-1-20210212","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.2042-7158.1989.tb06346.x","article-title":"A note on the use of salicylate saliva concentration in clinical pharmacokinetic studies","volume":"41","author":"Khan","year":"1989","journal-title":"J Pharm Pharmacol"},{"key":"R42-1-20210212","first-page":"113","article-title":"Blood and saliva salicylate measurement in the monitoring of salicylate therapy","volume":"15","author":"Perez-Mateo","year":"1977","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"R43-1-20210212","first-page":"229","article-title":"Determination of salicylic acid by HPLC in plasma and saliva from children with juvenile chronic arthritis","volume":"17","author":"Legaz","year":"1992","journal-title":"Tokai J Exp Clin Med"},{"key":"R44-1-20210212","doi-asserted-by":"crossref","first-page":"285S","DOI":"10.1111\/j.1365-2125.1980.tb01811.x","article-title":"Clinical pharmacokinetics of salicylates: a re-assessment","volume":"10","author":"Levy","year":"1980","journal-title":"Br J Clin Pharmacol"},{"key":"R45-1-20210212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2125.1992.tb04041.x","article-title":"The effect of pirenzepine on gastric emptying and salivary flow rate: constraints on the use of saliva paracetamol concentrations for the determination of paracetamol pharmacokinetics","volume":"33","author":"Kamali","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"R46-1-20210212","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/taap.2001.9191","article-title":"An alternative promoter contributes to tissue- and inducer-specific expression of the rat UDP-glucuronosyltransferase 1A6 Gene","volume":"174","author":"Auyeung","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"R47-1-20210212","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/humu.9432","article-title":"Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus","volume":"27","author":"Thomas","year":"2006","journal-title":"Hum Mutat"},{"key":"R48-1-20210212","doi-asserted-by":"crossref","first-page":"36164","DOI":"10.1074\/jbc.M002180200","article-title":"Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine","volume":"275","author":"Strassburg","year":"2000","journal-title":"J Biol Chem"},{"key":"R49-1-20210212","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/mol.52.2.212","article-title":"Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue","volume":"52","author":"Strassburg","year":"1997","journal-title":"Mol Pharmacol"},{"key":"R50-1-20210212","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0026-895X(24)13065-9","article-title":"Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium","volume":"54","author":"Strassburg","year":"1998","journal-title":"Mol Pharmacol"},{"key":"R51-1-20210212","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1006\/bbrc.1998.8843","article-title":"Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon","volume":"247","author":"Mojarrabi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R52-1-20210212","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/endo.142.2.7958","article-title":"Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members","volume":"142","author":"Turgeon","year":"2001","journal-title":"Endocrinology"},{"key":"R53-1-20210212","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/clpt.1984.81","article-title":"Disposition of and clinical response to salicylates in patients with rheumatoid disease","volume":"35","author":"Gunsberg","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"R54-1-20210212","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0885-4505(86)90076-9","article-title":"Acyl-CoA: glycine N-acyltransferase: in vitro studies on the glycine conjugation of straight- and branched-chained acyl-CoA esters in human liver","volume":"35","author":"Gregersen","year":"1986","journal-title":"Biochem Med Metab Biol"},{"key":"R55-1-20210212","first-page":"234","article-title":"Availability of glycine and coenzyme A limits glycine conjugation in vivo","volume":"20","author":"Gregus","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"R56-1-20210212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/096032719000900606","article-title":"Depletion of plasma glycine and effect of glycine by mouth on salicylate metabolism during aspirin overdose","volume":"9","author":"Patel","year":"1990","journal-title":"Hum Exp Toxicol"},{"key":"R57-1-20210212","article-title":"The PDR for herbal medicines","author":"Gruenwald","year":"1998"},{"key":"R58-1-20210212","article-title":"The green pharmacy herbal handbook","author":"Duke","year":"2000"},{"key":"R59-1-20210212","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2710.2002.00444.x","article-title":"Herbal medication: potential for adverse interactions with analgesic drugs","volume":"27","author":"Abebe","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"R60-1-20210212","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jcp.56.9.651","article-title":"Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin","volume":"56","author":"Lawrence","year":"2003","journal-title":"J Clin Pathol"},{"key":"R61-1-20210212","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1124\/jpet.104.081950","article-title":"UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5\u2032-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation","volume":"313","author":"Krishnaswamy","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R62-1-20210212","first-page":"550","article-title":"Effect of urinary pH on the pharmacokinetics of salicylic acid, with its glycine and glucuronide conjugates in human","volume":"32","author":"Vree","year":"1994","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.fpc.0000236339.79916.07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T01:48:45Z","timestamp":1738201725000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200708000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fpc.0000236339.79916.07","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}